The proposed bill, General Assembly Proposed Bill No. 6278, aims to amend current statutes to mandate that manufacturers and contract testing facilities utilize alternatives to animal testing methods whenever other approved methods are available. This requirement aligns with the guidelines set forth in the Food and Drug Administration Modernization Act of 2023.

The bill emphasizes the importance of reducing reliance on animal testing by ensuring that when viable alternatives exist, they must be employed instead. This legislative change reflects a growing trend towards more humane and ethical testing practices in various industries, promoting the use of innovative methods that do not involve animals.